AI Power Surges and Tech Restructurings: Key Moves Across 10 Niche Plays
Global Report·- Southern Company secured a 3200 megawatt electricity contract with OpenAI and reported 1.2 billion USD in Q2 2026 net income. - Luminar Technologies entered Chapter 11 bankruptcy protection to sell assets, while Generate Biomedicines reached a 52 week high with 450 million USD in cash. - Zhihu, The Honest Company, Hecla Mining, and British American Tobacco reported strategic transformations alongside Q2 2026 financial updates.EXCLUSIVE: Nvidia GPUs Are Essential—But They Won't Decide Who Wins AI Drug Discovery, Generate CTO Says
benzinga_article·- Generate Biomedicines CTO Gevorg Grigoryan stated that Nvidia GPUs are essential for AI drug discovery, but they do not guarantee a competitive advantage. - The true differentiator in the market lies in combining computing power with proprietary biological data, large-scale experimentation, and continuous feedback loops. - This perspective highlights a shift for investors toward evaluating biotech platforms that can generate and learn from unique datasets rather than relying solely on infrastructure.Top 10 US Stock Gainers (8.25)
Top Gainers&Losers·QUICK SPARK: Nvidia-Backed Biotech Says AI Could Make Biology Programmable
benzinga_article·- NVIDIA disclosed a stake in Generate Biomedicines Inc in its latest Form 13F filing to support its vision of making biology programmable through AI. - Generate Biomedicines integrates large-scale AI generation with high-throughput experimentation to transform drug discovery from scarce educated guesses into machine-scale hypothesis testing. - This continuous test-and-learn cycle aims to test orders of magnitude more hypotheses, ultimately increasing the probability of clinical success and delivering better medicines.EXCLUSIVE: Nvidia's Biggest Contribution to AI Drug Discovery Isn't Money, Generate CTO Says
benzinga_article·- Generate Biomedicines co-founder and CTO Gevorg Grigoryan stated that Nvidia's primary contribution to AI drug discovery extends beyond financial investment. - The collaboration features technical exchanges regarding accelerated computing, software optimization, and efficient execution of demanding biological workloads. - This partnership highlights Nvidia's expanding role as a strategic technology partner that helps companies scale AI applications.